Sunday, November 1

Browsing: dystrophic

General

DEBRA research invests in Topadur to advance small-molecule therapies for dystrophic Epidermolysis bullosa

By Healthcare Propulsion StaffOctober 28, 20260

DEBRA Research gGmbH, a global non-profit organization dedicated to advancing research and drug development for Epidermolysis bullosa (EB), and Topadur…

What's Hot

At risk Cumbrian in-person postpartum mums’ groups saved

Radiologists warn cancer patients ‘deteriorating’ amid staff shortages

Bringing medical innovation to market starts with understanding the clinician

Browsing: dystrophic

DEBRA research invests in Topadur to advance small-molecule therapies for dystrophic Epidermolysis bullosa

Successful food franchises that started in Utah and a few to watch

Costco apple pie sundae with soft serve is $2.99 for limited time

‘Leaving something delicious on the plate would be a far worse crime’: How Italy’s guiltiest food ritual went public

NHS leaders say maternity care organisation is ‘not fit for purpose’

At risk Cumbrian in-person postpartum mums’ groups saved

Radiologists warn cancer patients ‘deteriorating’ amid staff shortages

Bringing medical innovation to market starts with understanding the clinician

Kazakh Ophthalmologist Puts Down Roots in Hong Kong With Award-Winning Eye-Tech Venture

Our Picks

At risk Cumbrian in-person postpartum mums’ groups saved

Radiologists warn cancer patients ‘deteriorating’ amid staff shortages

Subscribe to Updates

What's Hot

Browsing: dystrophic

Subscribe to Updates